Anaptysbio (ANAB) Equity Ratio (2016 - 2026)

Anaptysbio has reported Equity Ratio for 11 years, with the latest figure at 0.04 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 52.03% year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (down 52.03% YoY), and the FY2025 full-year result was 0.1, down 30.28% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.04, down from 0.1 in the prior quarter.
• The five-year high for Equity Ratio was 0.53 in Q1 2022, with the low at 0.13 in Q2 2025.
• Historically, Equity Ratio has averaged 0.2 across 5 years, with a median of 0.17 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio declined 22.53% — and 2025, when it plunged 677.24%.
• Anaptysbio's Equity Ratio stood at 0.43 in 2022, then slumped by 54.65% to 0.19 in 2023, then slipped by 24.79% to 0.15 in 2024, then sank by 30.28% to 0.1 in 2025, then sank by 62.14% to 0.04 in 2026.
• The last three Equity Ratio figures came in at 0.04 (Q1 2026), 0.1 (Q4 2025), and 0.08 (Q3 2025), per Business Quant data.